Welcome to our Journey

Restart Life Sciences is dedicated to developing health-related foods that promote both mind and body wellness for healthy living. Our mission is to create innovative, nutrient-rich products that support mental clarity, physical vitality, and overall well-being. By focusing on holistic nutrition, we aim to empower individuals to lead healthier, more balanced lives. 

Restart Life Sciences and Brain Balls Inc entered into a Joint Venture to advance Brain Balls' innovative cognitive health products. The collaboration focuses on developing all-natural solutions targeting  cognitive health. The joint venture highlights both companies' shared dedication to prioritizing consumer well-being and delivering results-driven wellness products.

We are partnered with KGK Science to conduct the Phase IIA clinical trial which is being carried out at the KGK facility in London, Ontario, Canada. This 10-person, open-label study will assess repetitive, oral low-dose psilocybin therapy for FXS. The Company intends to confirm changes in behavioural symptoms with state-of-the-art diagnostic and therapeutic mRNA and serotonin biomarker technology, combined with machine learning artificial intelligence (AI).

Our commitment to excellence drives us to push the boundaries of innovation and deliver impactful products that enhance quality of life.

CFO

Ms. Hudson is a Chartered Professional Accountant (CPA, CA) with over 23 years of experience in accounting and financial reporting, corporate finance, risk management, financial audit and corporate governance, serving a range of industries, including mining and exploration, oil and gas, cannabis, manufacturing and retail, and not-for-profit. 

Ms. Hudson has served as CFO, and consulted for, a number of publicly-listed resource companies with projects in North and South America and across Europe. Ms. Hudson holds a Bachelor’s Degree and a Masters of Accounting from the University of Waterloo. 

She is a strategic, senior financial leader with a proven record in building financial operations and developing talent in growth-focused organizations.

Director

Ms. Harrycharran is a seasoned marketing professional with extensive experience in account management within the health and wellness sectors. She has a proven record of delivering strategic results and exceptional productization delivery, all while maintaining disciplined financial oversight. Ms. Harrycharran specializes in fostering strong client relationships and orchestrating cross-functional teams to execute impactful marketing campaigns.

Passionate about the dynamic worlds of health and wellness, Ms. Harrycharran remains committed to staying ahead of industry trends, leveraging data-driven insights and delivering exceptional service that builds lasting partnerships.

Director

Dr. Hochwimmer is chief analyst at General Research GmbH, a leading Munich-based securities research and analysis firm. Dr. Hochwimmer is a noted business consultant and academic responsible for aiding in the development of several highly profitable companies throughout Europe. 

He serves as the chief executive officer of supraMAT Technologies AG, which is a business incubator for German technology companies. He founded leading German technical start-ups, such as NGP Polymers, SmartDyelivery and Trophosys. He is also a managing director of Microdrop Technologies, which is a globally leading 3-D microprinting company. 

Dr. Hochwimmer has earned advanced degrees in chemistry and mechanical engineering.

Corporate Administrator

Kelly Pladson has provided corporate governance and regulatory compliance services to many TSX Venture and CSE listed companies since 2009. 

She works closely with the company’s CEO and legal counsel in maintaining corporate records, managing the day to day operations of the company and ensuring the company’s filings with the securities commissions and exchanges are accurately filed and in accordance with their deadlines. Prior to 2009, Ms. Pladson was an investment advisor’s assistant for two years.